These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36154663)

  • 1. Selective biomarkers for inflammation and infection are associated with post-operative complications following transperineal template prostate biopsy (TTPB): a single-centre observational clinical pilot-study.
    Snyper NYF; Pike J; Ekwueme K; Shergill I; Hughes SF
    Eur J Med Res; 2022 Sep; 27(1):187. PubMed ID: 36154663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression.
    Banzola I; Mengus C; Wyler S; Hudolin T; Manzella G; Chiarugi A; Boldorini R; Sais G; Schmidli TS; Chiffi G; Bachmann A; Sulser T; Spagnoli GC; Provenzano M
    Front Immunol; 2018; 9():1051. PubMed ID: 29896191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy.
    Losa A; Gadda GM; Lazzeri M; Lughezzani G; Cardone G; Freschi M; Lista G; Larcher A; Nava LD; Guazzoni G
    Urology; 2013 Jun; 81(6):1291-6. PubMed ID: 23522299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of erectile dysfunction after transperineal template prostate biopsy.
    Tan JL; Papa N; Hanegbi U; Snow R; Grummet J; Mann S; Cuthbertson A; Frydenberg M; Moon D
    Investig Clin Urol; 2021 Mar; 62(2):159-165. PubMed ID: 33660442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients.
    Hughes SF; Moyes AJ; Lamb RM; Ella-Tongwiis P; Bell C; Moussa A; Shergill I
    BMC Urol; 2020 Aug; 20(1):122. PubMed ID: 32795278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient experience after transperineal template prostate biopsy compared to prior transrectal ultrasound guided prostate biopsy.
    Bhatt NR; Breen K; Haroon UM; Akram M; Flood HD; Giri SK
    Cent European J Urol; 2018; 71(1):43-47. PubMed ID: 29732206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study.
    Dwivedi S; Goel A; Natu SM; Mandhani A; Khattri S; Pant KK
    Asian Pac J Cancer Prev; 2011; 12(7):1843-8. PubMed ID: 22126577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening, identification of prostate cancer urinary biomarkers and verification of important spots.
    Zhao H; Zhao X; Lei T; Zhang M
    Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differences in pathological features of histological inflammation between benign prostatic hyperplasia and prostate cancer].
    Yang L; Zhao K; Zhang A; Liu LR; Liu ZH; Han P; Wei Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):760-3, 768. PubMed ID: 24325107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy.
    Chen Y; Zhou Z; Zhou Y; Wu X; Xiao Y; Ji Z; Li H; Yan W
    BMC Urol; 2021 Apr; 21(1):68. PubMed ID: 33892696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
    König JE; Senge T; Allhoff EP; König W
    Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.
    Arivazhagan J; Nandeesha H; Dorairajan LN; Sreenivasulu K
    Aging Male; 2017 Jun; 20(2):115-118. PubMed ID: 28590830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.
    Mengus C; Le Magnen C; Trella E; Yousef K; Bubendorf L; Provenzano M; Bachmann A; Heberer M; Spagnoli GC; Wyler S
    J Transl Med; 2011 Sep; 9():162. PubMed ID: 21943235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).
    Kammerer-Jacquet SF; Compérat E; Egevad L; Hes O; Oxley J; Varma M; Kristiansen G; Berney DM
    Virchows Arch; 2018 Apr; 472(4):599-604. PubMed ID: 29327138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
    Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
    Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Liu Y; Zhao X; Sun X; Li Y; Wang Z; Jiang J; Han H; Shen W; Corrigan CJ; Sun Y
    Prostate; 2015 Dec; 75(16):1844-56. PubMed ID: 26356122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre.
    Kum F; Jones A; Nigam R
    World J Urol; 2019 Feb; 37(2):337-342. PubMed ID: 29974188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.